| |
| |
|
| Insider
Information: |
D Alonzo Thomas |
| Relationship: |
Acting President and C... |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
Acting President and C... |
2015-04-01 |
0 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
• • – |
2015-04-01 |
4 |
D |
$173.00 |
$3,164,170 |
I/I |
(18,290) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
• • – |
2015-04-01 |
4 |
D |
$173.00 |
$3,638,536 |
D/D |
(21,032) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
• • – |
2015-04-01 |
4 |
D |
$173.00 |
$12,898,015 |
D/D |
(74,555) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Acting Chief Executive Officer |
• • – |
2015-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,662 |
95,587 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-08-22 |
4 |
A |
$158.30 |
$504,186 |
D/D |
3,185 |
80,925 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-06-13 |
4 |
D |
$113.80 |
$163,758 |
D/D |
(1,439) |
77,740 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-04-22 |
4 |
AS |
$110.22 |
$1,278,577 |
D/D |
(11,530) |
79,179 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-04-17 |
4 |
A |
$100.66 |
$320,602 |
D/D |
3,185 |
90,709 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-01-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,450 |
10,450 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-01-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,450 |
87,524 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-01-10 |
4 |
AS |
$91.83 |
$1,106,603 |
D/D |
(12,050) |
97,974 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-01-10 |
4 |
OE |
$18.87 |
$424,575 |
D/D |
22,500 |
110,024 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2013-06-13 |
4 |
D |
$65.04 |
$67,642 |
D/D |
(1,040) |
87,524 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2013-04-18 |
4 |
A |
$48.70 |
$200,157 |
D/D |
4,110 |
88,564 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2013-04-08 |
4 |
OE |
$7.60 |
$114,000 |
D/D |
15,000 |
90,640 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2013-04-08 |
4 |
AS |
$49.43 |
$306,670 |
D/D |
(6,186) |
84,454 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-06-08 |
4 |
S |
$51.63 |
$131,657 |
I/I |
(2,550) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-06-08 |
4 |
S |
$51.63 |
$361,410 |
D/D |
(7,000) |
75,640 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,160 |
82,640 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-01-03 |
4 |
D |
$47.85 |
$55,506 |
D/D |
(1,160) |
78,480 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-08-11 |
4 |
B |
$29.77 |
$17,267 |
I/I |
580 |
1,080 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-08-11 |
4 |
B |
$29.45 |
$3,240 |
D/D |
110 |
69,340 |
2.31 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-07-01 |
4 |
D |
$39.83 |
$43,415 |
D/D |
(1,090) |
69,230 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,640 |
70,320 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-12-01 |
4 |
B |
$44.80 |
$22,399 |
I/I |
500 |
500 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
